Status:
UNKNOWN
the Role of Repetitive Trans Cranial-magnetic Stimulation in Craving Reduction Among Opioid Use Disorder Patients
Lead Sponsor:
Ain Shams University
Conditions:
Substance Use Disorders
Eligibility:
MALE
18-45 years
Phase:
NA
Brief Summary
Repetitive Trans-cranial Magnetic Stimulation (rTMS) is a relatively safe and non-invasive method to modulate neuronal activity; rTMS uses alternating magnetic fields in a certain frequency to induce ...
Eligibility Criteria
Inclusion
- Age range: 18-45 years old
- Gender: males
- Opioid Use disorder according to the DSM-5 (early abstinence starting 1 week up to 1 month).
Exclusion
- Presence of other serious mental illness (e.g.; psychotic disorders, bipolar affective disorder, depression with psychotic features).
- Patients with any other serious medical illness.
- Previous treatment with repetitive Trans- cranial magnetic stimulation.
- Patients with contraindications to rTMS as cardiac patient with pacemaker.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04691167
Start Date
June 1 2022
End Date
October 1 2022
Last Update
April 14 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.